On Nov 04, 2025, HNGE reported earnings of 0.44 USD per share (EPS) for Q3 25, beating the estimate of 0.22 USD, resulting in a 92.14% surprise. Revenue reached 154.21 million, compared to an expected 144.98 million, with a 6.37% difference. The market reacted with a +6.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of 0.40 USD, with revenue projected to reach 159.77 million USD, implying an decrease of -9.09% EPS, and increase of 3.61% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
FAQ
What were Hinge Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Hinge Health, Inc. reported EPS of $0.44, beating estimates by 92.14%, and revenue of $154.21M, 6.37% above expectations.
How did the market react to Hinge Health, Inc.'s Q3 2025 earnings?
The stock price moved up 6.16%, changed from $50.34 before the earnings release to $53.44 the day after.
When is Hinge Health, Inc. expected to report next?
The next earning report is scheduled for Feb 10, 2026.
What are the forecasts for Hinge Health, Inc.'s next earnings report?
Based on --
analysts, Hinge Health, Inc. is expected to report EPS of $0.40 and revenue of $159.77M for Q4 2025.